首页> 美国卫生研究院文献>Laboratory Animal Research >Unexpected effects of ivermectin and selamectin on inducible CreER activity in mice
【2h】

Unexpected effects of ivermectin and selamectin on inducible CreER activity in mice

机译:Ivermectin和Selamectin对小鼠诱导克利尔活性的意外影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ivermectin-induced silencing of Ela1-CreER in the pancreas. Representative immunofluorescent images of postnatal day 21 pancreata. Sections are labeled with antibodies against amylase (red) for acinar cells and YFP (green) for expression of the Rosa26lsl-YFP reporter of Cre activity. Colabeled with DAPI (blue, faint) for nuclei. Genotype and treatment group are indicated above images. No groups were administered tamoxifen at any time. Column 1 shows no YFP expression in untreated mice lacking the Ela1-CreER transgene (3/3 mice analyzed). Column 2 shows constitutive Ela1-CreER activity in untreated mice (7/7 double transgenic mice analyzed). Column 3 shows constitutive Ela1-CreER activity in spite of ivermectin treatment (2/6 double trangenic mice analyzed) whereas column 4 shows lost constitutive Ela1-CreER activity following ivermectin treatment (4/6 double transgenic mice analyzed)
机译:Ivermectin-诱导胰腺的ELA1-CREER的沉默。产后第21天胰腺炎的代表性免疫荧光图像。将切片用针对丙氨酸细胞和YFP(绿色)的抗体对抗淀粉酶(红色),用于表达CRE活性的ROSA26LSL-YFP报告。用DAPI(蓝色,微弱)共和的核。基因型和治疗组在图像上表明。任何时候没有群体给予他莫昔芬。第1柱显示未经处理的小鼠中没有YFP表达,缺乏ELA1-rear转基因(分析3/3小鼠)。第2柱显示未处理小鼠的组成型ELA1 - 克利尔活性(分析7/7双转基因小鼠)。柱3显示了本构ELA1-克利赫活性,尽管伊维菌素治疗(分析了2/6双长长的小鼠),而第4栏显示伊维菌素治疗后丢失的组成型ELA1 - 克利尔活性(分析4/6双转基因小鼠)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号